Advances in progenitor cell therapy using scaffolding constructs for central nervous system injury

Area of Science:

• Neuroscience
• Regenerative Medicine
• Biomaterials Engineering

Background:

• Traumatic brain injury (TBI) is a leading cause of death and disability, with current treatments focusing on acute care and rehabilitation.
• Adult progenitor (stem) cell therapies offer potential for TBI recovery but face challenges in effective delivery and engraftment.
• Traditional delivery methods like intravenous and intra-arterial infusions have limitations, including low cell engraftment and risk of emboli.

Purpose of the Study:

• To review current and novel methods for delivering progenitor cells for TBI treatment.
• To explore the potential of innovative delivery systems, such as nanofiber scaffolds, for enhancing progenitor cell therapy efficacy.
• To bridge the gap between pre-clinical findings and clinical translation of progenitor cell therapies for TBI.

Main Methods:

• Review of existing literature on progenitor cell delivery for TBI.
• Analysis of pre-clinical studies investigating various cell delivery techniques.
• Exploration of novel biomaterial-based delivery systems, including nanofiber scaffolds.

Main Results:

• Intracerebral milieu optimization and rehabilitation are current TBI management cornerstones.
• Pre-clinical studies highlight the promise of adult progenitor cell therapies for TBI.
• Nanofiber scaffolds present a promising novel delivery method for improved progenitor cell proliferation, engraftment, and differentiation.

Conclusions:

• Effective delivery of progenitor cells is critical for successful TBI therapy.
• Nanofiber scaffolds offer a potential solution to enhance progenitor cell engraftment and therapeutic efficacy in TBI.
• Further research into novel delivery methods is essential for translating progenitor cell therapies into clinical practice for TBI.